X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (271) 271
humans (241) 241
male (124) 124
female (109) 109
somatostatin - analogs & derivatives (99) 99
endocrinology & metabolism (93) 93
middle aged (92) 92
octreotide (88) 88
adult (85) 85
long-acting somatostatin (84) 84
long-acting octreotide (82) 82
octreotide - therapeutic use (77) 77
somatostatin (73) 73
somatostatin - therapeutic use (66) 66
oncology (59) 59
acromegaly (56) 56
aged (56) 56
long-acting formulation (53) 53
animals (52) 52
treatment outcome (52) 52
pharmacology & pharmacy (50) 50
somatostatin analogs (50) 50
acromegaly - drug therapy (49) 49
medicine & public health (44) 44
gastroenterology & hepatology (43) 43
lanreotide (43) 43
management (41) 41
therapy (40) 40
efficacy (38) 38
care and treatment (36) 36
peptides, cyclic - therapeutic use (36) 36
somatostatin - administration & dosage (36) 36
antineoplastic agents - therapeutic use (34) 34
follow-up (34) 34
antineoplastic agents, hormonal - therapeutic use (32) 32
cancer (32) 32
abridged index medicus (31) 31
neuroendocrine tumors (31) 31
octreotide - administration & dosage (31) 31
diabetes (30) 30
growth-hormone (30) 30
tumors (30) 30
urology & nephrology (30) 30
research (29) 29
neuroendocrine tumors - drug therapy (28) 28
polycystic kidney disease (28) 28
analysis (25) 25
peptides, cyclic - administration & dosage (25) 25
quality of life (25) 25
expression (24) 24
insulin (24) 24
internal medicine (24) 24
somatostatin - adverse effects (24) 24
clinical trials (23) 23
delayed-action preparations (23) 23
liver-disease (23) 23
long-acting release (23) 23
octreotide - adverse effects (23) 23
hepatocellular carcinoma (22) 22
liver neoplasms - drug therapy (22) 22
medicine, general & internal (22) 22
polycystic kidney, autosomal dominant - drug therapy (22) 22
aged, 80 and over (21) 21
health aspects (21) 21
carcinoma, hepatocellular - drug therapy (20) 20
disease progression (20) 20
drug therapy (20) 20
endocrinology (20) 20
growth hormone (20) 20
pharmacokinetics (20) 20
somatostatin analog (20) 20
term treatment (20) 20
chemotherapy (19) 19
growth-factor-i (19) 19
injections, subcutaneous (19) 19
octreotide lar (19) 19
pancreatic neoplasms - drug therapy (19) 19
peptides, cyclic - adverse effects (19) 19
surgery (19) 19
adolescent (18) 18
insulin glargine (18) 18
slow-release lanreotide (18) 18
somatostatin receptors (18) 18
diagnosis (17) 17
placebo (17) 17
analogs (16) 16
dose-response relationship, drug (16) 16
igf-i (16) 16
kidney diseases (16) 16
prognosis (16) 16
secreting pituitary-adenomas (16) 16
somatostatin analogues (16) 16
acromegalic patients (15) 15
adpkd (15) 15
everolimus (15) 15
glucose (15) 15
patients (15) 15
pituitary neoplasms - drug therapy (15) 15
pituitary-adenomas (15) 15
review (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9903, pp. 1485 - 1495
Journal Article
Current Drug Targets, ISSN 1389-4501, 04/2016, Volume 17, Issue 5, pp. 529 - 537
Journal Article
Internal Medicine, ISSN 0918-2918, 2017, Volume 56, Issue 18, pp. 2455 - 2461
Journal Article
Neuroendocrinology, ISSN 0028-3835, 09/2015, Volume 102, Issue 1-2, pp. 18 - 25
Journal Article
Experimental Biology and Medicine, ISSN 1535-3702, 9/2018, Volume 243, Issue 13, pp. 1092 - 1098
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2017, Volume 17, Issue 1, pp. 896 - 896
Background: Hepatocellular (HCC) and cholangiocellular carcinomas (CCC) display an exceptionally poor prognosis. Especially for advanced disease no efficient... 
CXCR4 | Hepatocellular carcinoma | Cholangiocellular carcinoma | Chemokine receptor | Somatostatin receptors | SURVIVAL | PLACEBO | CXCL12/CXCR4 | METASTASIS | MANAGEMENT | SORAFENIB | CANCER | LONG-ACTING OCTREOTIDE | ONCOLOGY | LIVER | EPIDEMIOLOGY | Immunohistochemistry | Monoclonal antibodies | Care and treatment | Prognosis | Health aspects | Cancer | Index Medicus
Journal Article
Hepato-Gastroenterology, ISSN 0172-6390, 10/2013, Volume 60, Issue 127, pp. 1693 - 1697
Background/Aims: Somatostatin analogues are considered for the treatment of advanced hepatocellular carcinomas which express somatostatin receptors (SSTR).... 
Immunohistochemistry | Hepatocellular carcinoma | SSTR1 | SSTR5 | SURGERY | DIAGNOSIS | PLACEBO | ANALOGS | TUMOR | CANCER | LONG-ACTING OCTREOTIDE | THERAPY | LIVER | ADVANCED HCC | GASTROENTEROLOGY & HEPATOLOGY
Journal Article